GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 200,000 | $11.11M |
| Open-market sale | 9 | 19,504 | $1.15M |
| Grant or award | 7 | 60,929 | |
| Option exercise | 22 | 114,256 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
79 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Restricted Stock Unit | 35,441 | $0.00 | - | ||
| Jason Ryan | Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | |
| Jason Ryan | Option exercise | Class A Common Stock | 3,576 | $0.00 | - | |
| Joshua Ruch | Option exercise | Class A Common Stock | 3,576 | $0.00 | - | |
| Joshua Ruch | Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | |
| Joshua Ruch | Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | |
| Richard C. Pfenniger Jr. | Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | |
| Richard C. Pfenniger Jr. | Option exercise | Class A Common Stock | 3,576 | $0.00 | - | |
| Richard C. Pfenniger Jr. | Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | |
| Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 3,576 | $0.00 | - | ||
| Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | ||
| Emily M. Leproust | Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | |
| Emily M. Leproust | Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | |
| Emily M. Leproust | Option exercise | Class A Common Stock | 3,576 | $0.00 | - | |
| Thomas Fuchs | Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | |
| Eli Casdin | Option exercise | Restricted Stock Unit | 3,576 | $0.00 | - | |
| Eli Casdin | Option exercise | Class A Common Stock | 3,576 | $0.00 | - | |
| Eli Casdin | Grant or award | Restricted Stock Unit | 4,248 | $0.00 | - | |
| Open-market sale | Class A Common Stock | 760 | $59.75 | $45K | ||
| Open-market sale | Class A Common Stock | 2,106 | $60.83 | $128K | ||
| Open-market sale | Class A Common Stock | 863 | $61.50 | $53K | ||
| Option exercise | Restricted Stock Unit | 7,197 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 7,197 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 2,140 | $59.75 | $128K | ||
| Open-market sale | Class A Common Stock | 5,932 | $60.83 | $361K | ||
| Open-market sale | Class A Common Stock | 2,429 | $61.50 | $149K | ||
| Option exercise | Restricted Stock Unit | 18,750 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 18,750 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 1,266 | $53.77 | $68K | ||
| Option exercise | Restricted Stock Unit | 2,462 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 2,462 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 3,639 | $53.77 | $196K | ||
| Option exercise | Restricted Stock Unit | 6,546 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 6,546 | $0.00 | - | ||
| Casdin Capital, LLC - Director | Open-market purchase | Class A Common Stock, par value $0.0001 per share | 150,000 | $56.44 | $8.47M | |
| Casdin Capital, LLC - Director | Open-market purchase | Class A Common Stock, par value $0.0001 per share | 50,000 | $52.86 | $2.64M | |
| Option exercise | Class A Common Stock | 717 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 369 | $51.74 | $19K | ||
| Option exercise | Restricted Stock Unit | 717 | $0.00 | - | ||
| Casdin Capital, LLC - Director | Open-market purchase | Class A Common Stock, par value $0.0001 per share | 175,000 | $42.55 | $7.45M | |
| Casdin Capital, LLC - Director | Open-market purchase | Class A Common Stock, par value $0.0001 per share | 185,000 | $42.60 | $7.88M | |
| Casdin Capital, LLC - Director | Open-market purchase | Class A Common Stock, par value $0.0001 per share | 140,000 | $43.81 | $6.13M | |
| Open-market purchase | Class A Common Stock | 94,074 | $38.82 | $3.65M | ||
| Open-market purchase | Class A Common Stock | 70,926 | $39.45 | $2.80M | ||
| Open-market purchase | Class A Common Stock | 88,107 | $39.08 | $3.44M | ||
| Open-market purchase | Class A Common Stock | 51,893 | $39.92 | $2.07M | ||
| Open-market purchase | Class A Common Stock | 27,408 | $38.28 | $1.05M | ||
| Open-market purchase | Class A Common Stock | 18,865 | $39.83 | $751K | ||
| Open-market purchase | Class A Common Stock | 128,181 | $35.46 | $4.55M | ||
| Open-market purchase | Class A Common Stock | 14,786 | $36.33 | $537K | ||
| Open-market purchase | Class A Common Stock | 123,393 | $37.60 | $4.64M | ||
| Open-market purchase | Class A Common Stock | 116,412 | $38.46 | $4.48M | ||
| Open-market purchase | Class A Common Stock | 94,356 | $39.39 | $3.72M | ||
| Open-market purchase | Class A Common Stock | 56,630 | $40.46 | $2.29M | ||
| Open-market purchase | Class A Common Stock | 15,745 | $38.00 | $598K | ||
| Open-market purchase | Class A Common Stock | 3,396 | $38.70 | $131K | ||
| Open-market purchase | Class A Common Stock | 79,144 | $40.67 | $3.22M | ||
| Open-market purchase | Class A Common Stock | 73,104 | $41.15 | $3.01M | ||
| Open-market purchase | Class A Common Stock | 246,734 | $38.91 | $9.60M | ||
| Open-market purchase | Class A Common Stock | 252,734 | $39.65 | $10.02M | ||
| Open-market purchase | Class A Common Stock | 532 | $40.35 | $21K | ||
| Casdin Capital, LLC - Director | Open-market purchase | Cash Settled Swap | 500,000 | - | - | |
| Casdin Capital, LLC - Director | Open-market purchase | Cash Settled Swap | 300,000 | - | - | |
| Casdin Capital, LLC - Director | Open-market purchase | Cash Settled Swap | 50,000 | - | - | |
| Option exercise | Class A Common Stock | 3,874 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 2,154 | $65.20 | $140K | ||
| Open-market sale | Class A Common Stock | 18 | $64.12 | $1K | ||
| Option exercise | Restricted Stock Unit | 3,874 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 754 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 392 | $65.19 | $26K | ||
| Option exercise | Restricted Stock Unit | 754 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 16,250 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 2,485 | $61.29 | $152K | ||
| Open-market sale | Class A Common Stock | 961 | $62.33 | $60K | ||
| Open-market sale | Class A Common Stock | 2,520 | $63.28 | $159K | ||
| Open-market sale | Class A Common Stock | 995 | $64.60 | $64K | ||
| Open-market sale | Class A Common Stock | 1,857 | $65.21 | $121K | ||
| Option exercise | Restricted Stock Unit | 16,250 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 80,000 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 13,229 | $61.29 | $811K | ||
| Open-market sale | Class A Common Stock | 5,117 | $62.33 | $319K | ||
| Open-market sale | Class A Common Stock | 13,412 | $63.28 | $849K | ||
| Open-market sale | Class A Common Stock | 5,292 | $64.60 | $342K | ||
| Open-market sale | Class A Common Stock | 9,883 | $65.21 | $645K | ||
| Option exercise | Restricted Stock Unit | 80,000 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 11,921 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 18,750 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 7,178 | $76.35 | $548K | ||
| Open-market sale | Class A Common Stock | 9,229 | $77.05 | $711K | ||
| Open-market sale | Class A Common Stock | 772 | $77.94 | $60K | ||
| Option exercise | Restricted Stock Unit | 11,921 | $0.00 | - | ||
| Option exercise | Restricted Stock Unit | 18,750 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 3,815 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 7,197 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 2,384 | $76.35 | $182K | ||
| Open-market sale | Class A Common Stock | 3,065 | $77.05 | $236K | ||
| Open-market sale | Class A Common Stock | 257 | $77.94 | $20K | ||
| Option exercise | Restricted Stock Unit | 3,815 | $0.00 | - | ||
| Option exercise | Restricted Stock Unit | 7,197 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 1,280 | $86.75 | $111K | ||
| Option exercise | Restricted Stock Unit | 2,462 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 2,462 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 6,546 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 3,678 | $86.75 | $319K | ||
| Option exercise | Restricted Stock Unit | 6,546 | $0.00 | - | ||
| Grant or award | Class A Common Stock | 1,986 | $88.11 | $175K | ||
| Grant or award | Class A Common Stock | 3,404 | $88.11 | $300K | ||
| Open-market purchase | Class A Common Stock | 47,623 | $80.55 | $3.84M | ||
| Open-market purchase | Class A Common Stock | 60,892 | $81.37 | $4.95M | ||
| Open-market purchase | Class A Common Stock | 29,236 | $82.06 | $2.40M | ||
| Open-market purchase | Class A Common Stock | 19,686 | $70.34 | $1.38M | ||
| Open-market purchase | Class A Common Stock | 8,439 | $71.48 | $603K | ||
| Open-market purchase | Class A Common Stock | 200 | $72.00 | $14K | ||
| Open-market purchase | Class A Common Stock | 921 | $75.66 | $70K | ||
| Open-market purchase | Class A Common Stock | 249 | $75.99 | $19K | ||
| Open-market purchase | Class A Common Stock | 304 | $77.96 | $24K | ||
| Open-market purchase | Class A Common Stock | 1,971 | $78.91 | $156K | ||
| Grant or award | Restricted Stock Unit | 10,430 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
GeneDx Holdings Corp. (WGS) had 14 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for WGS runs to 79 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of WGS were filed in the last 90 days, totaling $11.11M.
9 insider sales of WGS were filed in the last 90 days, totaling $1.15M.
This page tracks WGS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add WGS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.